Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Momenta Pharma (MNTA)

Momenta Pharma (MNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,246,641
  • Shares Outstanding, K 119,029
  • Annual Sales, $ 23,870 K
  • Annual Income, $ -290,060 K
  • 60-Month Beta 1.78
  • Price/Sales 261.77
  • Price/Cash Flow N/A
  • Price/Book 15.63
Trade MNTA with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.23
  • Most Recent Earnings -0.45 on 10/31/19
  • Next Earnings Date 10/29/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.47
  • Number of Estimates 6
  • High Estimate -0.43
  • Low Estimate -0.51
  • Prior Year -0.56
  • Growth Rate Est. (year over year) +16.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
52.02 +0.88%
on 09/11/20
52.53 -0.10%
on 09/30/20
+0.15 (+0.29%)
since 08/28/20
3-Month
26.86 +95.38%
on 08/11/20
52.53 -0.10%
on 09/30/20
+19.21 (+57.74%)
since 06/30/20
52-Week
12.21 +329.81%
on 10/02/19
52.53 -0.10%
on 09/30/20
+39.52 (+304.94%)
since 09/30/19

Most Recent Stories

More News
Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 140.05 (+0.49%)
MNTA : 52.48 (-0.02%)
NEOG : 72.29 (+1.25%)
NEO : 41.34 (-2.64%)
XLV : 107.82 (+0.37%)
VHT : 209.85 (+0.46%)
Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & Johnson

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, "Momenta" or the "Company"), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases,...

MNTA : 52.48 (-0.02%)
Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc.

, /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Momenta Pharmaceuticals, Inc. ("Momenta"), a company that discovers and develops novel...

MNTA : 52.48 (-0.02%)
JNJ : 145.24 (+0.11%)
Momenta Pharmace Shares Up 0.8% Since SmarTrend's Buy Recommendation (MNTA)

SmarTrend identified an Uptrend for Momenta Pharmace (NASDAQ:MNTA) on August 19th, 2020 at $52.07. In approximately 1 month, Momenta Pharmace has returned 0.79% as of today's recent price of $52.48.

MNTA : 52.48 (-0.02%)
Chesapeake Utilities to Join S&P SmallCap 600

, /PRNewswire/ -- Chesapeake Utilities Corp (NYSE:CPK) will replace Momenta Pharmaceuticals Inc (NASD:MNTA) in the S&P SmallCap 600 effective prior to the opening of trading on . S&P 500 constituent Johnson...

CPK : 93.89 (+1.15%)
MNTA : 52.48 (-0.02%)
JNJ : 145.24 (+0.11%)
SPGI : 337.43 (+0.05%)
Should You Invest in the Invesco SP SmallCap Health Care ETF (PSCH)?

Sector ETF report for PSCH

PSCH : 140.05 (+0.49%)
MNTA : 52.48 (-0.02%)
NEOG : 72.29 (+1.25%)
NEO : 41.34 (-2.64%)
XLV : 107.82 (+0.37%)
VHT : 209.85 (+0.46%)
MERGER ALERT - SBPH, IMMU, and MNTA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

NEW YORK, NY / ACCESSWIRE / September 21, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:

SBPH : 1.2700 (unch)
IMMU : 87.86 (+0.05%)
MNTA : 52.48 (-0.02%)
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating:

VAR : 172.56 (+0.48%)
MNTA : 52.48 (-0.02%)
AIMT : 34.49 (-0.29%)
GLIBA : 80.72 (-0.68%)
MERGER ALERT - ONK and MNTA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

NEW YORK, NY / ACCESSWIRE / September 17, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:

ONDK : 1.8300 (-3.17%)
MNTA : 52.48 (-0.02%)
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Rosetta Stone, Momenta, Jernigan, and Varian on behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Rosetta Stone Inc. (NYSE: RST), Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), Jernigan...

MDSY : 0.73 (+4.29%)
RST : 29.99 (unch)
MNTA : 52.48 (-0.02%)
JCAP : 17.23 (unch)
VAR : 172.56 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Momenta Pharmaceuticals is a leader in the analysis, characterization and design of complex pharmaceutical products. Their scientific foundation is a set of tools and methods that allow them to develop a deep understanding of the links between a compound's chemical structure, biological function and...

See More

Key Turning Points

2nd Resistance Point 52.56
1st Resistance Point 52.52
Last Price 52.48
1st Support Level 52.45
2nd Support Level 52.42

See More

52-Week High 52.53
Last Price 52.48
Fibonacci 61.8% 37.13
Fibonacci 50% 32.37
Fibonacci 38.2% 27.61
52-Week Low 12.21

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar